Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib for Prevention of Post-ERCP Pancreatitis
NCT02964403Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Dec 2016
- Primary completion
- Feb 2018
01
Overview
A Phase 4 trial of parecoxib in acute pancreatitis (AP), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
parecoxib
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02964403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02964403.